![Alexander Shneider](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander Shneider
Chief Executive Officer at CureLab Oncology, Inc.
Alexander Shneider active positions
Companies | Position | Start | End |
---|---|---|---|
CureLab Oncology, Inc.
![]() CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Chief Executive Officer | - | - |
Chairman | - | - | |
Founder | - | - |
Career history of Alexander Shneider
Statistics
International
United States | 2 |
Operational
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
CureLab Oncology, Inc.
![]() CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Alexander Shneider
- Experience